Health Anxiety Is a Market

The best health-tech trade in India right now is the machinery that gets paid every time someone gets worried.

That sounds almost too simple, but it’s the cleanest way to read the market. The consumer layer is private, the listed layer is infrastructure, and the real monetization happens when anxiety turns into a claim, a scan, a subscription, or a test. If you’re looking for where the public-market exposure sits, it’s not in the shiny wellness narrative. It’s in the plumbing underneath it.

India’s health economy is large enough, messy enough, and anxious enough to keep generating transactions. The country has 101 million people living with diabetes and 136 million more with pre-diabetes — which means the demand for screening, monitoring, and follow-up is not theoretical. It’s already here, and it’s broadening. That matters because the more people live inside a diagnosis, the more they buy measurement, interpretation, and reassurance.

A 101 million-person problem nobody can ignore

India doesn’t just have a health challenge — it has a recurring revenue challenge disguised as a public health problem. The ICMR numbers make the point cleanly, because they show how deeply metabolic disease is embedded in the population. The nuance matters here. A lot of health commentary stops at prevalence, but the investable question is conversion. How many people move from “I should probably check this” to “I need a claim, a test, a monitor, or a consult”? That conversion is where consumer fear becomes a market structure story.

And the market keeps feeding it. India’s health insurance premiums crossed roughly Rs 1.2 lakh crore in FY25, growing about 9 per cent, which tells you the pool is expanding even before you ask who clips the fee.

The step count was marketing

Sometimes the cleanest way to understand a market is to admit that a lot of its most familiar signals are designed, not discovered.

Ten thousand steps was not a scientific commandment. It came from a 1960s Japanese pedometer campaign. BMI, the number that still sits on health dashboards and screening sheets, was formalized by a mathematician in the 19th century. Orthosomnia is now a real clinical term for people who get anxious about their sleep data. The pattern is obvious once you see it. A health metric becomes a habit, a habit becomes a product, and a product becomes a recurring billing engine.

This is why the wellness economy is so sticky. People don’t just want to be healthy — they want to feel that they’re managing risk. That need creates demand for devices, apps, reports, checkups, and interpretation layers. In finance language, this is a behavior loop with high repeatability and low emotional switching costs.

It also explains why some of the biggest consumer trends in health are really just rebranded anxiety. The ₹999 full-body checkup exists because uncertainty sells. CGMs get worn by healthy people because they’ve become symbols of discipline, not just medical devices. And sleep tracking can create the very anxiety it claims to solve. It’s part of the retention strategy.

Fear sells, but trust clears

Once you understand the fear funnel, the product-market fit starts to look different.

Protein powders are a useful example because they sit right at the intersection of aspiration and unease. A 2024 study on popular protein supplements sold in India found mislabeling and contamination issues — which is exactly the kind of fact pattern that turns a commodity category into a trust category. People buy confidence that they’re not being gamed.

That’s where the story gets more interesting. The category looks like consumer health on the surface, but underneath, it behaves like a quality-control market. The better the fear narrative, the more consumers pay for verification, certification, and premium branding. And the worse the regulatory environment, the more value accrues to whoever can look credible at scale.

The listed toll road

Health insurance premiums in India are growing, and that growth turns into claims. Claims turn into processing. Processing turns into admin revenue. So even if the consumer brand stays private, the infrastructure around it can still be public and profitable. In other words, the listed winners are not the most visible brands — the toll collectors are.

Medi Assist is the cleanest example of that logic. Publicly available reporting says its AI-powered platforms process nearly 1 million claims a month, which makes the scale visible enough to matter and boring enough to underwrite. The business is not selling fantasy. It is managing throughput.

Krsnaa Diagnostics Ltd sits in a different but related lane. Its tele-radiology network exists because India does not have enough specialists in the right places at the right time. That shortage is not a side note — it is the product. When scans are taken where doctors are scarce and read remotely, the business is monetizing a structural gap in healthcare delivery.

The interesting part is that both models benefit from the same underlying engine. More health awareness means more tests. More tests mean more interpretation. More insured lives mean more claims. More claims mean more admin. The market doesn’t need every consumer app to list. It just needs the rails that convert activity into cash flow.

The air got into the thesis

Bryan Johnson came to India in 2025 and made air quality the headline. That detail matters because it turns a macro problem into a personal one. Air pollution is not just policy debt — it becomes a wearable metric, a filter purchase, a health worry, and eventually a budget line. That’s exactly how fear becomes monetizable in India.

And once that happens, the market expands beyond the obvious categories. Air quality creates demand for filtration. Sleep anxiety creates demand for trackers. Metabolic anxiety creates demand for CGMs, lab tests, and diet products. Protein fear creates demand for certified brands. Health anxiety is not one market. It is a stack of adjacent markets that all convert worry into spend.

The real payoff

The consumer story is the bait. The listed story is the fee. Every extra test, claim, scan, monitor, and premium creates a transaction somewhere in the chain. That means the most interesting public-market exposure is not the brand that gets shared on Instagram. It’s the business that sits quietly between worry and resolution.

That’s also why the macro matters so much. India’s diabetes burden is large, health insurance is growing, wearable adoption has expanded, and trust in food and supplement categories is under pressure. Put those together and you get a durable market for measurement, admin, diagnostics, and reassurance. The opportunity is not a single product. It’s the infrastructure that keeps getting paid when people keep asking the same anxious question.

What we’re watching

Health insurance premium growth, because it tells you how fast the claims pool is expanding.

Medi Assist claim volumes and retention, because that shows whether the toll-road model is actually sticky.

Krsnaa’s tele-radiology and retail mix, because that tells you whether diagnostics demand is broadening beyond PPP dependence.

Consumer trust signals in supplements and wellness, because the more the category gets questioned, the more value shifts toward verified brands and regulated rails.